Submitted by NCIIA Guest on Thu, 09/27/2012 - 21:25
In August of 2009, Stanford University student Ben Cline and D-Rev CEO Krista Donaldson came to the first Sustainable Vision Advanced Invention to Venture (AI2V) workshop in Cambridge. Three years later, their product, Brilliance, a low cost, low maintenance opto-medical device to treat neonatal jaundice, is on the market in India and they are looking to expand to East Africa. Donaldson estimates that early data suggests 13 babies will get treatment per device per month in urban hospitals, which means lives saved and brain damage averted. These results will be closely tracked. Cline’s contribution has been instrumental in early stages of product development of Brilliance. His accomplishments, during later stages, in an advisory role to bring Brilliance to Point-of-Scale are also commendable. His early partnership with D-Rev, was a key factor to this success.
Note: This article has been corrected since its original post to address some factual errors.
Submitted by NCIIA Guest on Thu, 09/27/2012 - 21:15
Krista Donaldson, D-Rev CEO and Stanford d.school lecturer and Mariana Amatullo, cofounder and vice president of Designmatters at Art Center College of Design were named two of the 50 most influential designers "pushing the boundaries of their discipline into promising new directions."
Donaldson and Amatullo are both past recipients of NCIIA E-Team and Course & Program Grants. Amatullo and her students at Designmatters are responsible for the GiraDora, a manually powered washing machine designed to address issues related to water poverty and a notable entry in Fast Company's 2012 Innovation by Design Awards.
Submitted by NCIIA Guest on Fri, 11/18/2011 - 14:34
Sustainable Vision grantee Krista Donaldson now runs D-Rev: Design Revolution, which creates world class products - market and user driven - designed to meet the needs of the four billion people all over the world living on less than four dollars a day.
In 2009, NCIIA awarded $46,500 to Krista's Stanford University team to develop Brilliance, an affordable technology designed to treat neonatal jaundice in rural areas in India. Fast Company reported on Brilliance earlier this year.